Savara Inc Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Savara Inc (SVRA) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $5.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-13
- Savara Inc effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $5.00K.
- Savara Inc effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $16.00K, a 91.01% decline from fiscal 2022.
- Savara Inc effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $178.00K, a 709.09% increase from fiscal 2021.
- Savara Inc effective income tax rate reconciliation, other adjustments, amount for fiscal 2021 was $22.00K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $5.00K 10-K · filed 2026-03-13 | |
| 2023-12-31 | $16.00K 10-K · filed 2025-03-27 | |
| 2022-12-31 | $178.00K 10-K · filed 2024-03-07 | |
| 2021-12-31 | $22.00K 10-K · filed 2023-03-30 | |
| 2020-12-31 | -$135.00K 10-K · filed 2022-03-30 | -$1.21M 10-K · filed 2021-03-10 |
| 2019-12-31 | $854.00K 10-K · filed 2021-03-10 | |
| 2018-12-31 | $1.04M 10-K · filed 2020-03-12 | $987.00K 10-K · filed 2019-03-13 |
| 2017-12-31 | $486.00K 10-K · filed 2019-03-13 | |
| 2016-12-31 | $445.00K 10-K · filed 2018-03-14 | |
| 2015-12-31 | $188.00K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |